Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Citius Pharmaceuticals Inc CTXR

Healthcare Biotechnology
Citius Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and prescription products. The Company's FDA approved LYMPHIR candidate is a targeted immunotherapy for an initial indication in the treatment of cutaneous T... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CTXR)

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

PR Newswire February 14, 2025

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

PR Newswire February 6, 2025

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

PR Newswire January 8, 2025

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

PR Newswire January 7, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

PR Newswire December 27, 2024

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval

PR Newswire November 25, 2024

Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split

PR Newswire November 22, 2024

Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering

PR Newswire November 18, 2024

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering

PR Newswire November 15, 2024
View More News ››

Opinion & Analysis (NDAQ:CTXR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CTXR)

Big news out today for CTXR

https://youtu.be/tU1AzxFwptw?si=cOPKMeHbzN7wkKVX
BryceCanada - November 11, 2024

New video out on CTXR

https://youtu.be/W4lOTWn3uRY?si=_KnuRrHt8WGledKD
BryceCanada - September 23, 2024

New coverage out on CTXR

https://youtu.be/5rfNA18dGZM?si=JWS4rAcKdq-RrQJh
BryceCanada - July 16, 2024

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 20

Just In: $CTXR Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business UpdateCitius...
whytestocks - February 14, 2024

new CTXR research report - great read!

https://marketresearchrepository.com/cancer-breakthrough-of-the-decade/?utm_source=mcnalliemoney+&utm_medium=influencer&utm...
BryceCanada - May 3, 2022

Excellent YT analysis on Citius Pharmaceuticals!

https://youtu.be/hRHnqSPnhdU
BryceCanada - May 3, 2022
View more Bullboard ››

Graphite One Inc.

Graphite One Inc.

Graphite One Inc. is a Canada-based company, which is focused on developing its Graphite One Project. The Graphite One ...
View More »